A Lifespan Perspective on Accelerated Aging in Congenital Heart Disease
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- KU Leuven
- 入组人数
- 1,200
- 试验地点
- 2
- 主要终点
- Telomere length
研究概览
简要总结
Many childhood-onset diseases used to be lethal. Improved life expectancy yield that most patients can survive into adulthood, to date. However, survivors of childhood-onset diseases often develop morbidities that suggest accelerated aging. Indeed, age-related conditions are observed sooner and more frequently in people with childhood-onset diseases. Congenital heart disease (CHD) is a typical example of a childhood-onset disease and is the most common birth defect, comprising a spectrum of mild, moderate and complex heart defects. Recent studies showed that age-related morbidities occur more often and at an earlier age in these patients. The overall goal of this project is to quantify and understand disparities in chronological and biological age over the lifespan in CHD patients.
详细描述
Three main research objectives are proposed:
Objective 1: The investigators will determine the biological age in patients with CHD across the lifespan, using established and novel biomarkers for aging, and assess the disparity with chronological age.
Objective 2: The investigators will identify clinical, behavioral, psychological and social predictors of aging in patients with CHD.
Objective 3: The investigators will investigate the difference in biological-chronological age disparity between patients with CHD and healthy counterparts.
Three studies will be performed to investigate these objectives:
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Telomere length
时间窗: Baseline
Telomere length will be measured on umbilical cord blood from newborns and on peripheral blood from adults with and without CHD.
次要结局
- Fall history as a functional outcome of aging in adults with CHD(Baseline)
- Cognitive impairment as a functional outcome of aging in adults with CHD(Baseline)
- Epigenetic clock in adults with and without CHD(Baseline)
- Retina scan in adults with CHD(Baseline)
- Clinical, behavioral, psychological and social predictors of telomere length(Baseline)
- hsCRP in adults with CHD(Baseline)
- Frailty as a functional outcome of aging in adults with CHD(Baseline)
